Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2024Blood AdvancesOpen Access

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMaría Agustina PerusiniDŽDaniela ŽáčkováTKTae‐Hyung Kim

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Perusini et al. (2024) studied this question.

synapsesocial.com/papers/68e75695b6db6435876ce6f2https://doi.org/10.1182/bloodadvances.2023012127
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia2010 · 1,602 citations
  2. 2Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia2020 · 155 citations
  3. 3Sequencing error profiles of Illumina sequencing instruments2021 · 478 citations
  4. 4Modeling cumulative incidence function for competing risks data2008 · 81 citations
  5. 5Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation2022 · 27 citations